https://pubmed.ncbi.nlm.nih.gov/33588436/
A Stronger Innate Immune Response During Hyperacute Human Immunodeficiency Virus Type 1 (HIV-1)...
A stronger innate immune response during hAHI was associated with ARS. Plasma IP-10 may be a candidate biomarker of stronger innate immunity. Our findings...
human immunodeficiency virus
https://pubmed.ncbi.nlm.nih.gov/39826543/
Hyperacute rejection-engineered oncolytic virus for interventional clinical trial in refractory...
Recently, oncolytic virus (OV) therapy has shown great promise in treating malignancies. However, intravenous safety and inherent lack of immunity are two...
oncolytic virusclinical trialrejectionengineered
https://pubmed.ncbi.nlm.nih.gov/41629171/
Transcranial direct current stimulation is safe and feasible in hyperacute ischemic stroke...
Cathodal transcranial direct current stimulation (C-tDCS) is a potential neuroprotective method in the hyperacute phase of ischemic stroke. We aimed to assess...
direct current
https://pubmed.ncbi.nlm.nih.gov/38752650/
Intensive Ambulance-Delivered Blood-Pressure Reduction in Hyperacute Stroke
In this trial, prehospital blood-pressure reduction did not improve functional outcomes in a cohort of patients with undifferentiated acute stroke, of whom...
blood pressureintensiveambulancedeliveredreduction
https://portal.fis.tum.de/en/publications/the-contribution-of-terminal-complement-components-to-acute-and-h/
The contribution of terminal complement components to acute and hyperacute allograft rejection in...